Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma

Mount Sinai School of Medicine Mt Sinai, New York

Duke University Medical Center Duke SC, Durham

Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2), Atlanta

H. Lee Moffitt Cancer Center & Research Institute SC - 3, Tampa

Indiana University Indiana Univ, Indianapolis

Novartis Investigative Site, Lille

Washington University School of Medicine Dept. of WUSTL, St Louis

Novartis Investigative Site, Heidelberg

Highlands Oncology Group Dept of Highlands Oncology Grp, Fayetteville

Novartis Investigative Site, Würzburg

Fred Hutchinson Cancer Research Center Fred Hutchinson, Seattle

Dana Farber Cancer Institute DFCI (2), Boston

Hackensack University Medical Center Multiple Myeloma Division, Hackensack